A research team at UC Santa Barbara has received a major grant from Wellcome Leap, announced on Mar. 19, to join a global initiative examining how the early-life gut microbiome may influence neurodevelopmental challenges such as autism spectrum disorder.
The project is part of Wellcome Leap’s Foundations of Resilient Microbiome (FORM) program, which focuses on understanding the role of the gut microbiome during pregnancy through age two—a period when this microbial ecosystem rapidly develops and may impact immune, metabolic, and neurological systems. The program seeks to determine if disruptions in the early-life microbiome contribute to neurodevelopmental differences and whether resilience in these communities can be measured or supported.
Led by chemical engineering professor Michelle O’Malley, the UC Santa Barbara team will use high-throughput experimental systems to investigate how early microbial communities respond to environmental exposures and how these changes affect biological pathways linked to brain development. “This program is exciting because it allows us to take the kind of bold, non-incremental steps that traditional funding models rarely support,” said O’Malley. “Wellcome Leap is explicitly focused on making big leaps in understanding. In this case, that means asking whether the early-life microbiome plays a causal role in neurodevelopment, and how resilience during this critical window might be better supported.”
The research will utilize ExFAB—the Biofoundry for Extreme & Exceptional Fungi, Archaea, and Bacteria—an automated facility established with National Science Foundation funding. This infrastructure enables cultivation of complex gut microbial communities under controlled conditions for systematic testing. “We’re essentially creating miniature, highly controlled versions of the gut so we can challenge them with different early-life environments — such as components of breast milk or antibiotic exposure — and observe how these communities evolve,” O’Malley said.
Jean Carlson and Holly Moeller are leading efforts to analyze data using modeling approaches from physics, mathematics, ecology, systems biology, machine learning and AI. “When you can observe how a system evolves, you can start to see which early changes actually matter, and which ones don’t,” Carlson explained. “That’s what allows us to connect biological mechanisms to developmental outcomes.”
Collaboration with Ty Vernon and Fernanda Castellón at UC Santa Barbara’s Koegel Autism Center ensures clinical perspectives inform experimental work. Vernon said: “This research offers the opportunity to move beyond speculation and toward data-driven understanding of how early biological systems interact with neurodevelopment… The knowledge provides a critical missing link that can help families, clinicians and educators make more informed decisions that support the neurodivergent community’s well-being and quality of life.”
Campus leaders highlighted the interdisciplinary nature of the project as key for advancing discovery with real-world impact. Chancellor Dennis Assanis said: “We are honored to have the partnership and transformative support of Wellcome Leap… It is a shining example of the interdisciplinary collaborative research that is a hallmark of our campus.”
O’Malley emphasized that their goal is not to “cure” autism but rather deepen scientific understanding: “We’re trying to understand the biological mechanisms of neurodivergence so we can better support individuals and families… That includes recognizing the strengths of neurodivergent people while also asking whether early biological insights could expand options for promoting health and well-being.”
